Molecular neuro-oncology - from basic research to clinical applications (Neuro-Oncology Parallel Session)
Tracks
Hall 6
| Monday, October 14, 2024 |
| 8:00 AM - 9:30 AM |
| Hall 07 |
Details
Oral Presentations duration (each): 7 minutes + 1 minute Q&A
Speakers & Chairs
Dr Franz Ricklefs
Attending, Principal Investigator
University Medical Center Hamburg-eppendorf
Chair
Prof Martin Van Den Bent
Head of the Neuro-Oncology
Erasmus Medical Center
Chair
Dr Franz Ricklefs
Attending, Principal Investigator
University Medical Center Hamburg-eppendorf
Methylation based subclassification of glioblastoma - clinical utility
8:00 AM - 8:10 AM
Dr Giuseppe Maria Della Pepa
Consultant
Fondazione Policlincio Gemelli Irccs
Dissecting the microenvironment of malignant gliomas: translational approaches and prognostic implications
8:10 AM - 8:20 AM
Prof Martin Van Den Bent
Head of the Neuro-Oncology
Erasmus Medical Center
INDIGO: A global, randomized, double-blinded, phase 3 study of vorasidenib versus placebo in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation
8:20 AM - 8:30 AM
Dr Harald Krenzlin
Attending
University Hospital Mainz
The role of surgery in IDH wildtype diffuse astrocytomas
8:30 AM - 8:37 AM
Dr Giuseppe Maimone
Doctor
AUSL della Romagna
Advances in postoperative adjuvant therapy for primary Glioblastoma. First results in an Autologous Dendritic Cells Vaccine phase II study.
8:37 AM - 8:44 AM
Dr Tobias Mederer
Resident
University Hospital Regensburg
Liquid biopsies in meningioma - plasma cell-free DNA as a potential biomarker for meningioma tumor burden
8:44 AM - 8:51 AM
Dr Aleksei Veselkov
Resident
Burdenko Neurosurgical Institute
Application Of The “Liquid Biopsy” Technique To Detect H3K27M And BRAF V600E Mutations In Patients With Diffuse Brainstem Tumors
8:51 AM - 8:58 AM
Dr Eric Freund
Resident
Medical University of Vienna
PSGL-1 and other markers of tumor-associated macrophages and microglial cells exhibit high intratumoral heterogeneity in human glioblastoma tissue
8:58 AM - 9:05 AM
Dr Manina Etter
Resident
University Hospital Basel
Identification of plasma-derived diagnostic and predictive biomarkers for gliomas
9:05 AM - 9:12 AM
Dr Tong Meng
Associate Chief Surgeon
Shanghai General Hospital
Clinical-proteomic classification and precision treatment strategy of chordoma
9:12 AM - 9:19 AM
Discussion
Discussion
9:19 AM - 9:30 AM
